About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Chicago | 164 Studies

Clinical Trials Alzheimer's DiseaseChicago

Alzheimer's Disease Clinical Trials in Chicago

Find 164 clinical trials for alzheimer's disease near Chicago, Illinois. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 164 trials

CompletedIntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for DepressionThis study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same…NCT02801877·Chicago, Illinois TerminatedA Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study was to test whether two investigational drugs called CAD106 and CNP520, administered separately, could slow down the onset and progression of clinical…NCT02565511·Phoenix, Arizona and 128 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAn Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeObjectives: The objective of this study will be to determine the safety, tolerability, drug blood levels, and efficacy of each of three doses of NS 2330 (Tesofensine) given once…NCT00153010·Mesa, Arizona and 86 others

CompletedStudy of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With DonepezilTo establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).NCT01955161·Birmingham, Alabama and 136 others

CompletedEffects of ONO-2506PO in Patients With Alzheimer's DiseaseThe purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.NCT00083421·Birmingham, Alabama and 86 others

TerminatedA Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)A study to evaluate the efficacy and safety of gantenerumab in amyloid-positive, cognitively unimpaired participants at risk for or at the earliest stages of AD.NCT05256134·Phoenix, Arizona and 62 others

CompletedDISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac AmyloidosisThe purpose of this study is to characterize the frequency of TTR mutations in subjects suspected of having cardiac amyloidosisNCT02252653·Little Rock, Arkansas and 57 others

CompletedA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD.NCT05637801·Gilbert, Arizona and 67 others

CompletedComparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineThe purpose of this study was to support the optimal use of rivastigmine patch in long-term treatment of Alzheimer's Disease in patients demonstrating functional and cognitive…NCT00506415·Birmingham, Alabama and 144 others

CompletedCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD).NCT00053599·Birmingham, Alabama and 43 others

CompletedEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyPhase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg administered orally twice a day compared to placebo in subjects with symptomatic Transthyretin Amyloid…NCT03860935·Los Angeles, California and 103 others

TerminatedOpen-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 ProtocolOpen-label treatment with MPC-7869 for participants in a previous randomized study.NCT00380276·Alabaster, Alabama and 89 others

CompletedA Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.NCT00566397·Phoenix, Arizona and 61 others

CompletedNegotiation Training for Caregiver Communication in ADThe purpose of this study is to design a Negotiation and Dispute Resolution (NDR) training intervention to improve communication and address resolution of conflicts that family…NCT04837937·Chicago, Illinois

SuspendedA Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.NCT04520412·Gilbert, Arizona and 170 others

TerminatedA Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaThis study is an extension of study I8D-MC-AZES (NCT02245737), the AMARANTH study.NCT02972658·Phoenix, Arizona and 132 others

RecruitingFeasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related OutcomesThis remote study will evaluate the feasibility of using the Gatorade Sports Science Institute (GSSI) Labs App for remotely collecting hydration related outcomes.NCT07005895·Chicago, Illinois

CompletedResveratrol for Alzheimer's DiseaseResveratrol is derived from plants and is found in highest levels in red wine and the skin of red grapes.NCT01504854·Phoenix, Arizona and 25 others

CompletedMemory Improvement Through Nicotine Dosing (MIND) StudyThe purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI.NCT02720445·Scottsdale, Arizona and 35 others

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

PreviousPage 7 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia